REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $274,059 | -79.9% | 22,687 | -82.4% | 0.00% | -100.0% |
Q2 2023 | $1,366,386 | +32202.3% | 129,148 | -70.0% | 0.00% | -50.0% |
Q1 2023 | $4,230 | -57.6% | 429,870 | -36.6% | 0.00% | -66.7% |
Q4 2022 | $9,970 | -99.7% | 677,787 | +174.1% | 0.01% | +200.0% |
Q3 2022 | $3,000,000 | +72.6% | 247,321 | +99.1% | 0.00% | +100.0% |
Q2 2022 | $1,738,000 | -44.6% | 124,195 | -43.6% | 0.00% | -50.0% |
Q1 2022 | $3,135,000 | -55.1% | 220,154 | -33.5% | 0.00% | -50.0% |
Q4 2021 | $6,977,000 | +55.1% | 330,826 | +92.9% | 0.00% | +33.3% |
Q3 2021 | $4,499,000 | +539.1% | 171,461 | +659.2% | 0.00% | – |
Q2 2021 | $704,000 | -78.4% | 22,585 | -76.2% | 0.00% | -100.0% |
Q4 2020 | $3,259,000 | -44.1% | 95,018 | -49.9% | 0.00% | -71.4% |
Q3 2020 | $5,835,000 | -15.7% | 189,645 | -15.1% | 0.01% | -22.2% |
Q2 2020 | $6,925,000 | – | 223,244 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |